Low doses of amitriptyline, pregabalin, and gabapentin are preferred for management of neuropathic pain in India: is there a need for revisiting dosing recommendations?
| Autor: | Lyndon Lincoln D'souza, Sanjay Kamble, Vinay Nanda Kudrigikar, Sameer Eknath Rao, Salman Motlekar |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Gabapentin
Dose Amitriptyline Sedation Pregabalin Administration and dosage Neuropathic pain 03 medical and health sciences 0302 clinical medicine medicine 030212 general & internal medicine Dosing business.industry Maintenance dose Prescriptions Anesthesiology and Pain Medicine Anesthesia Original Article medicine.symptom Surveys and questionnaires business Analysis 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | The Korean Journal of Pain |
| ISSN: | 2093-0569 2005-9159 |
| Popis: | Background Current therapy for the treatment of neuropathic pain is often unsatisfactory. Considerable variation in treatment pattern still exists in spite of availability of sufficient literature from various guidelines. Recent Indian market data suggested that the utilization (sale) of drugs such as amitriptyline, pregabalin, and gabapentin was more for low-dose unit packs than that of the high-dose unit packs, raising the belief that these drugs are prescribed at a lower dose than is actually recommended in the guidelines. To test this hypothesis, a survey was conducted across speciality throughout the country to observe the prescription pattern of these drugs amongst the health care providers in India. Methods Three hundred fifty survey forms were distributed of which 281 forms were included for analysis. Results It was observed that the commonly used initiation and maintenance dose for amitriptyline, pregabalin, and gabapentin was 5–10 mg/day, 50–75 mg/day, and 100–300 mg/day, respectively. The reason to select the lower dosages was to have a balancing effect to achieve good efficacy with minimum side effects. Care-givers reported no side effects/not many side effects as a reason in 22.2%, 16.88%, and 23.86% patients with amitriptyline, pregabalin, and gabapentin, respectively. Sedation and giddiness were commonly reported with all three drugs. Conclusions Commonly prescribed drugs for management of neuropathic pain, such as amitriptyline, pregabalin, and gabapentin are preferred at lower doses in Indian clinical settings. Acceptable efficacy and low tolerance to the standard dosage is believed to be the reason behind the prescribed dose. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|